Literature DB >> 12634362

Transcriptional suppression of in vitro-integrated human immunodeficiency virus type 1 does not correlate with proviral DNA methylation.

Marjorie Pion1, Albert Jordan, Angelique Biancotto, Franck Dequiedt, Françoise Gondois-Rey, Sophie Rondeau, Robert Vigne, Jiri Hejnar, Eric Verdin, Ivan Hirsch.   

Abstract

Persistence of human immunodeficiency virus type 1 (HIV-1) constitutes a major obstacle in the control of HIV-1 infection. Here we investigated whether the CpG methylation of the HIV-1 promoter can directly influence the expression of the HIV-1 genome and thereby contribute to the persistence and latency of HIV-1. The levels of CpG methylation in the promoter of HIV-1 were studied after bisulfite-induced modification of DNA in five Jurkat clonal cell lines transduced by an HIV-1 long terminal repeat (LTR)-driven retroviral vector and expressing enhanced green fluorescent protein (GFP) and in primary resting memory T cells challenged with HIV-1 or with an HIV-1-derived retroviral vector. Basal HIV-1 promoter activities were low or undetectable in three tested HIV-1 LTR-GFP clones, one of which encoded the Tat protein, and they reached medium or high levels in two other clones. The CpG dinucleotide that occurred in a latently infected clonal cell line 240 nucleotides upstream of the transcription start remained methylated after reactivation of HIV-1 transcription with 10 nM phorbol-12-myristate-13-acetate. In two clones showing a medium promoter activity and in resting memory T cells, the HIV-1 LTR was generally not methylated. Our results show that the methylation profiles of the HIV-1 LTR, including those present in latently infected cells, are low and do not correlate with the transcriptional activity. We suggest that, in a noncloned cellular population in which the HIV-1 proviruses are randomly integrated in the human genome, HIV-1 latency is imperfectly controlled by CpG methylation and is inherently accompanied by residual replication.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634362      PMCID: PMC150653          DOI: 10.1128/jvi.77.7.4025-4032.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo.

Authors:  J A Mikovits; N C Lohrey; R Schulof; J Courtless; F W Ruscetti
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

2.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.

Authors:  T Folks; J Kelly; S Benn; A Kinter; J Justement; J Gold; R Redfield; K W Sell; A S Fauci
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

4.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de novo methylation.

Authors:  J Y Fang; J A Mikovits; R Bagni; C L Petrow-Sadowski; F W Ruscetti
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Transcription of the HIV-1 LTR is regulated by the density of DNA CpG methylation.

Authors:  K A Gutekunst; F Kashanchi; J N Brady; D P Bednarik
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-06

7.  Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1.

Authors:  F d'Adda di Fagagna; G Marzio; M I Gutierrez; L Y Kang; A Falaschi; M Giacca
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Independent mechanisms involved in suppression of the Moloney leukemia virus genome during differentiation of murine teratocarcinoma cells.

Authors:  O Niwa; Y Yokota; H Ishida; T Sugahara
Journal:  Cell       Date:  1983-04       Impact factor: 41.582

Review 9.  Cytosine methylation and the ecology of intragenomic parasites.

Authors:  J A Yoder; C P Walsh; T H Bestor
Journal:  Trends Genet       Date:  1997-08       Impact factor: 11.639

10.  High sensitivity mapping of methylated cytosines.

Authors:  S J Clark; J Harrison; C L Paul; M Frommer
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

View more
  30 in total

1.  High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms.

Authors:  Richard A Katz; Emily Jack-Scott; Anna Narezkina; Ivan Palagin; Pamela Boimel; Joseph Kulkosky; Emmanuelle Nicolas; James G Greger; Anna Marie Skalka
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

2.  Mobilization-competent Lentiviral Vector-mediated Sustained Transcriptional Modulation of HIV-1 Expression.

Authors:  Anne-Marie W Turner; Justin De La Cruz; Kevin V Morris
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

Review 3.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

4.  An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection.

Authors:  Alexandra Duverger; Frank Wolschendorf; Mingce Zhang; Fredric Wagner; Brandon Hatcher; Jennifer Jones; Randall Q Cron; Renee M van der Sluis; Rienk E Jeeninga; Ben Berkhout; Olaf Kutsch
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

Review 5.  Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.

Authors:  Sonia Shah; Michael R Nonnemacher; Vanessa Pirrone; Brian Wigdahl
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

6.  Epigenetic analysis of HIV-1 proviral genomes from infected individuals: predominance of unmethylated CpG's.

Authors:  Stefanie Weber; Barbara Weiser; Kimdar S Kemal; Harold Burger; Christina M Ramirez; Klaus Korn; Kathryn Anastos; Rupert Kaul; Colin Kovacs; Walter Doerfler
Journal:  Virology       Date:  2013-12-05       Impact factor: 3.616

7.  Determinants of the establishment of human immunodeficiency virus type 1 latency.

Authors:  Alexandra Duverger; Jennifer Jones; Jori May; Frederic Bibollet-Ruche; Frederic A Wagner; Randall Q Cron; Olaf Kutsch
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

Review 8.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

9.  CpG methylation controls reactivation of HIV from latency.

Authors:  Jana Blazkova; Katerina Trejbalova; Françoise Gondois-Rey; Philippe Halfon; Patrick Philibert; Allan Guiguen; Eric Verdin; Daniel Olive; Carine Van Lint; Jiri Hejnar; Ivan Hirsch
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

Review 10.  Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.

Authors:  Evelyn M Kilareski; Sonia Shah; Michael R Nonnemacher; Brian Wigdahl
Journal:  Retrovirology       Date:  2009-12-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.